NSC305787
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 462527

CAS#: 785718-37-8 (free base)

Description: NSC305787 is a small molecule ezrin inhibitor. Ezrin is a key driver of tumor progression and metastatic spread of osteosarcoma. NSC305787 directly binds to ezrin and inhibits its functions in promoting invasive phenotype. NSC-305787 reduces the incidence of lung metastasis in a genetically engineered mouse model of osteosarcoma. NSC305787 exhibits antineoplastic activity in pancreatic cancer cells


Chemical Structure

img
NSC305787
CAS# 785718-37-8 (free base)

Theoretical Analysis

MedKoo Cat#: 462527
Name: NSC305787
CAS#: 785718-37-8 (free base)
Chemical Formula: C25H30Cl2N2O
Exact Mass: 444.17
Molecular Weight: 445.428
Elemental Analysis: C, 67.41; H, 6.79; Cl, 15.92; N, 6.29; O, 3.59

Price and Availability

Size Price Availability Quantity
5mg USD 750 2 Weeks
10mg USD 1250 2 Weeks
Bulk inquiry

Related CAS #: 785718-37-8 (free base)   53868-26-1 (HCl)    

Synonym: NSC305787; NSC 305787; NSC-305787

IUPAC/Chemical Name: (2-(adamantan-1-yl)-6,8-dichloroquinolin-4-yl)(piperidin-2-yl)methanol

InChi Key: YNGQUUFYBFKLNH-UHFFFAOYSA-N

InChi Code: InChI=1S/C25H30Cl2N2O/c26-17-8-18-19(24(30)21-3-1-2-4-28-21)10-22(29-23(18)20(27)9-17)25-11-14-5-15(12-25)7-16(6-14)13-25/h8-10,14-16,21,24,28,30H,1-7,11-13H2

SMILES Code: OC(C1NCCCC1)C2=CC(C3(C4)CC5CC4CC(C5)C3)=NC6=C(Cl)C=C(Cl)C=C26

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: NSC305787 is an inhibitor of ezrin with a Kd of 5.85 μM, inhibits the phosphorylation of ezrin caused by PKCΙ with an IC50 of 8.3 μM.
In vitro activity: This study assessed the potential antineoplastic effects of NSC305787 in pancreatic cancer cell lines. In pancreatic cells, NSC305787 reduced cell viability, clonal growth, and migration. This study’s exploratory molecular studies identified that NSC305787 modulates the expression and activation of key regulators of the cell cycle, proliferation, DNA damage, and apoptosis, favoring a tumor-suppressive molecular network. Reference: Invest New Drugs. 2022 Aug;40(4):728-737. https://pubmed.ncbi.nlm.nih.gov/35477813/
In vivo activity: Treatment of mice with NSC305787 significantly suppressed pulmonary metastasis compared with the vehicle-treated control. Lung metastasis was observed only in 40% (4 of 10) of NSC305787-treated animals (p = 0.039, Fisher's exact test) (Fig. 3A). Taken together, these findings suggest that NSC305787 treatment inhibits ezrin-dependent lung metastasis of osteosarcoma. Reference: J Biol Chem. 2016 Jun 17;291(25):13257-70. https://pubmed.ncbi.nlm.nih.gov/27137931/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 6.0 13.47

Preparing Stock Solutions

The following data is based on the product molecular weight 445.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Lipreri da Silva JC, Carvalho MFL, de Miranda LBL, de Almeida BO, Lima K, Machado-Neto JA. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Invest New Drugs. 2022 Aug;40(4):728-737. doi: 10.1007/s10637-022-01249-z. Epub 2022 Apr 28. PMID: 35477813. 2. Chen C, Ye C, Xia J, Zhou Y, Wu R. Ezrin T567 phosphorylation regulates migration and invasion of ectopic endometrial stromal cells by changing actin cytoskeleton. Life Sci. 2020 Aug 1;254:117681. doi: 10.1016/j.lfs.2020.117681. Epub 2020 May 5. PMID: 32380081. 3. Çelik H, Bulut G, Han J, Graham GT, Minas TZ, Conn EJ, Hong SH, Pauly GT, Hayran M, Li X, Özdemirli M, Ayhan A, Rudek MA, Toretsky JA, Üren A. Ezrin Inhibition Up-regulates Stress Response Gene Expression. J Biol Chem. 2016 Jun 17;291(25):13257-70. doi: 10.1074/jbc.M116.718189. Epub 2016 May 2. PMID: 27137931; PMCID: PMC4933238. 4. Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene. 2012 Jan 19;31(3):269-81. doi: 10.1038/onc.2011.245. Epub 2011 Jun 27. PMID: 21706056; PMCID: PMC3513970.
In vitro protocol: 1. Lipreri da Silva JC, Carvalho MFL, de Miranda LBL, de Almeida BO, Lima K, Machado-Neto JA. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Invest New Drugs. 2022 Aug;40(4):728-737. doi: 10.1007/s10637-022-01249-z. Epub 2022 Apr 28. PMID: 35477813. 2. Chen C, Ye C, Xia J, Zhou Y, Wu R. Ezrin T567 phosphorylation regulates migration and invasion of ectopic endometrial stromal cells by changing actin cytoskeleton. Life Sci. 2020 Aug 1;254:117681. doi: 10.1016/j.lfs.2020.117681. Epub 2020 May 5. PMID: 32380081.
In vivo protocol: 1. Çelik H, Bulut G, Han J, Graham GT, Minas TZ, Conn EJ, Hong SH, Pauly GT, Hayran M, Li X, Özdemirli M, Ayhan A, Rudek MA, Toretsky JA, Üren A. Ezrin Inhibition Up-regulates Stress Response Gene Expression. J Biol Chem. 2016 Jun 17;291(25):13257-70. doi: 10.1074/jbc.M116.718189. Epub 2016 May 2. PMID: 27137931; PMCID: PMC4933238. 2. Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene. 2012 Jan 19;31(3):269-81. doi: 10.1038/onc.2011.245. Epub 2011 Jun 27. PMID: 21706056; PMCID: PMC3513970.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Lipreri da Silva JC, Saldanha-Araujo F, de Melo RCB, Vicari HP, Silva- Carvalho AE, Rego EM, Buccheri V, Machado-Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sci. 2022 Dec 15;311(Pt B):121146. doi: 10.1016/j.lfs.2022.121146. Epub 2022 Nov 3. PMID: 36336127.


2: Lipreri da Silva JC, Carvalho MFL, de Miranda LBL, de Almeida BO, Lima K, Machado-Neto JA. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Invest New Drugs. 2022 Aug;40(4):728-737. doi: 10.1007/s10637-022-01249-z. Epub 2022 Apr 28. PMID: 35477813.


3: Lipreri da Silva JC, Coelho-Silva JL, Lima K, Vicari HP, Lazarini M, Costa- Lotufo LV, Traina F, Machado-Neto JA. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Cell Oncol (Dordr). 2021 Oct;44(5):1105-1117. doi: 10.1007/s13402-021-00621-0. Epub 2021 Jul 1. PMID: 34196912.


4: Chen C, Ye C, Xia J, Zhou Y, Wu R. Ezrin T567 phosphorylation regulates migration and invasion of ectopic endometrial stromal cells by changing actin cytoskeleton. Life Sci. 2020 Aug 1;254:117681. doi: 10.1016/j.lfs.2020.117681. Epub 2020 May 5. PMID: 32380081.


5: Penchev VR, Chang YT, Begum A, Ewachiw T, Gocke C, Li J, McMillan RH, Wang Q, Anders R, Marchionni L, Maitra A, Uren A, Rasheed Z, Matsui W. Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma. Mol Cancer Res. 2019 Apr;17(4):929-936. doi: 10.1158/1541-7786.MCR-18-0367. Epub 2019 Jan 17. PMID: 30655325; PMCID: PMC6445733.


6: Çelik H, Bulut G, Han J, Graham GT, Minas TZ, Conn EJ, Hong SH, Pauly GT, Hayran M, Li X, Özdemirli M, Ayhan A, Rudek MA, Toretsky JA, Üren A. Ezrin Inhibition Up-regulates Stress Response Gene Expression. J Biol Chem. 2016 Jun 17;291(25):13257-70. doi: 10.1074/jbc.M116.718189. Epub 2016 May 2. PMID: 27137931; PMCID: PMC4933238.


7: Saygideğer-Kont Y, Minas TZ, Jones H, Hour S, Çelik H, Temel I, Han J, Atabey N, Erkizan HV, Toretsky JA, Üren A. Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells. Neoplasia. 2016 Feb;18(2):111-20. doi: 10.1016/j.neo.2016.01.002. PMID: 26936397; PMCID: PMC5005263.


8: Russo CM, Adhikari AA, Wallach DR, Fernandes S, Balch AN, Kerr WG, Chisholm JD. Synthesis and initial evaluation of quinoline-based inhibitors of the SH2-containing inositol 5'-phosphatase (SHIP). Bioorg Med Chem Lett. 2015 Nov 15;25(22):5344-8. doi: 10.1016/j.bmcl.2015.09.034. Epub 2015 Sep 15. PMID: 26453006; PMCID: PMC4628863.


9: Çelik H, Hong SH, Colón-López DD, Han J, Kont YS, Minas TZ, Swift M, Paige M, Glasgow E, Toretsky JA, Bosch J, Üren A. Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box. Mol Cancer Ther. 2015 Nov;14(11):2497-507. doi: 10.1158/1535-7163.MCT-15-0511. Epub 2015 Sep 10. PMID: 26358752; PMCID: PMC4636458.


10: Çelik H, Sajwan KP, Selvanathan SP, Marsh BJ, Pai AV, Kont YS, Han J, Minas TZ, Rahim S, Erkizan HV, Toretsky JA, Üren A. Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level. Mol Cell Biol. 2015 Sep;35(18):3145-62. doi: 10.1128/MCB.00332-15. Epub 2015 Jul 6. PMID: 26149384; PMCID: PMC4539380.


11: Ren L, Khanna C. Role of ezrin in osteosarcoma metastasis. Adv Exp Med Biol. 2014;804:181-201. doi: 10.1007/978-3-319-04843-7_10. PMID: 24924175.


12: Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene. 2012 Jan 19;31(3):269-81. doi: 10.1038/onc.2011.245. Epub 2011 Jun 27. PMID: 21706056; PMCID: PMC3513970.